Does AID aid AIDS?

Immunology Letters

Volumn 91, Issue 1, 2004, Pages 1-2

  Suslov, Konstantin V ^a,b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Activation induced cytidine deaminase (AID); gp120; HIV 1; R5 X4 switch; Somatic hypermutation

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTIDINE DEAMINASE; GLYCOPROTEIN GP 120; INTERLEUKIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; B LYMPHOCYTE; DISEASE COURSE; ENVELOPE GENE; GENE MUTATION; GENETIC CODE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; LARGE CELL LYMPHOMA; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SEQUENCE HOMOLOGY; SOMATIC HYPERMUTATION; T LYMPHOCYTE; UPREGULATION;

EID: 0742289553     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2003.11.002     Document Type: Letter

References (22)

1. Bomsel M., David V. Mucosal gatekeepers: selecting HIV viruses for early infection. Nat. Med. 8:2002;114-116.
2. Glushakova S., Grivel J.C., Fitzgerald W., Sylwester A., Zimmerberg J., Margolis L.B. Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency. Nat. Med. 4:1998;346-349.
3. Penn M.L., Grivel J.C., Schramm B., Goldsmith M.A., Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. U.S.A. 96:1999;663-668.
4. Galaktionov VG. Immunology. Moscow: MSU; 1997.
5. Cowell L.G., Kim H.J., Humaljoki T., Berek C., Kepler T.B. Enhanced evolvability in immunoglobulin V genes under somatic hypermutation. J. Mol. Evol. 49:1999;23-26.
6. Metlas R., Veljkovic V. Does the HIV-1 manipulate immune network via gp120 immunoglobulin-like domain involving V3 loop? Vaccine. 13:1995;355-359.
7. Veljkovic V., Metlas R. Identification of immunoglobulin recombinant elements in human immunodeficiency virus type 1 envelope gene. Immunol. Lett. 31:1992;11-14.
8. Metlas R., Skerl V., Veljkovic V., Pongor S. Further evidence for the relationship of HIV-1 gp120 V3 loops with Ig superfamily members: similarity with the putative CDR3 region of T-cell receptor delta-chains. Immunol. Lett. 47:1995;25-28.
9. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R.et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature. 412:2001;341-346.
10. Gaidano G., Pasqualucci L., Capello D., Berra E., Deambrogi C., Rossi D.et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood. 102:2003;1833-1841.
11. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K. et al. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197:2003;1173-1181.
12. De Silva F.S., Venturini D.S., Wagner E., Shank P.R., Sharma S. CD4-independent infection of human B cells with HIV type 1: detection of unintegrated viral DNA. AIDS Res. Hum. Retroviruses. 17:2001;1585-1598.
13. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:2000;553-563.
14. Moir S., Lapointe R., Malaspina A., Ostrowski M., Cole C.E., Chun T.W.et al. CD40-mediated induction of CD4 and CXCR4 on B lymphocytes correlates with restricted susceptibility to human immunodeficiency virus type 1 infection: potential role of B lymphocytes as a viral reservoir. J. Virol. 73:1999;7972-7980.
15. Nakayama E.E., Hoshino Y., Xin X., Liu H., Goto M., Watanabe N.et al. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J. Virol. 74:2000;5452-5459.
16. Faili A., Aoufouchi S., Gueranger Q., Zober C., Leon A., Bertocci B.et al. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 3:2002;815-821.
17. Berberian L., Goodglick L., Kipps T.J., Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science. 261:1993;1588-1591.
18. Malaspina A., Moir S., Nickle D.C., Donoghue E.T., Ogwaro K.M., Ehler L.A.et al. Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma. J. Virol. 76:2002;8855-8863.
19. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 424:2003;94-98.
20. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 424:2003;99-103.
21. Meng G., Wei X., Wu X., Sellers M.T., Decker J.M., Moldoveanu Z.et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 8:2002;150-156.
22. Fagarasan S., Kinoshita K., Muramatsu M., Ikuta K., Honjo T. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria. Nature. 413:2001;639-643.